Enanta Pharmaceuticals | Ventes



Sales Changement Date
AbbVie USD 13.34B 1.76B 2025-03
Amgen USD 8.15B 936M 2025-03
Arrowhead Research USD 542.71M 540.21M 2025-03
AstraZeneca USD 13.59B 1.3B 2025-03
Biogen USD 2.43B 24.7M 2025-03
Bristol-Myers Squibb USD 11.2B 1.14B 2025-03
Gilead Sciences USD 6.67B 899M 2025-03
GlaxoSmithKline GBP 7.52B 600M 2025-03
Halozyme Therapeutics USD 265M 33.01M 2025-03
Incyte USD 1.05B 128.7M 2025-03
Insmed USD 92.82M 11.62M 2025-03
Ionis Pharmaceuticals USD 132M 94.58M 2025-03
J&J USD 21.89B 630M 2025-03
Ligand Pharmaceuticals USD 45.33M 2.52M 2025-03
Merck USD 15.53B 94M 2025-03
Neurocrine Biosciences USD 572.6M 55.1M 2025-03
Novartis USD 13.15B 330M 2024-12
Pfizer USD 13.72B 4.04B 2025-03
PTC Therapeutics USD 190M 23.17M 2025-03
Roche Holding CHF 31.64B 883M 2024-12
Sarepta Therapeutics USD 774.9M 116.49M 2025-03
Vertex Pharmaceuticals USD 2.77B 142M 2025-03



Enanta Pharmaceuticals Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.